Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21933255 | 0.86 | EPHX2 (0.69) | EPHX2KDM4EMAPTRAB9ATRPV1 | |
| SCHEMBL19097940 | 0.85 | EPHX2 (0.70) | LMNAEPHX2KDM4EMAPTRAB9A | |
| SCHEMBL21933261 | 0.84 | EPHX2 (0.66) | EPHX2KDM4EMAPTRAB9AMEN1 | |
| SCHEMBL21933245 | 0.82 | KDM4E (0.81) | EPHX2KDM4EMAPTRAB9ATRPV1 | |
| SCHEMBL22639638 | 0.81 | EPHX2 (0.65) | EPHX2KDM4EMAPTRAB9ATRPV1 | |
| SCHEMBL21933248 | 0.80 | RAB9A (0.63) | EPHX2KDM4EMAPTRAB9AMEN1 | |
| SCHEMBL21933247 | 0.79 | EPHX2 (0.69) | EPHX2KDM4EMAPTRAB9ATRPV1 | |
| SCHEMBL21933291 | 0.79 | EPHX2 (1.00) | EPHX2KDM4EMAPTRAB9ATRPV1 | |
| SCHEMBL11766665 | 0.78 | ALDH1A1 (0.60) | LMNAKDM4EMAPTTRPV1MEN1 | |
| SCHEMBL11766659 | 0.78 | ALDH1A1 (0.60) | LMNAKDM4EMAPTTRPV1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148662-A1 | NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF | BEIJING INSTITUTE OF TECHNOLOGY (CN) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148662-A1 | NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF | STS, F12, STK38L | LMNA 1896/4885EPHX2 3354/4885KDM4E 4442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.